Fig. 4From: Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled studyProportions of subjects with freedom from nausea (a), photophobia (b), and phonophobia (c)Back to article page